Illumina, Inc. Cash Flow Statement
ILMN / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Illumina, Inc. generated $1.1B in operating cash flow and $931M in free cash flow in FY2025. Free cash flow margin was 21.4% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 29.5%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $850.0M | -$1.2B | -$1.2B | $656.0M | $762.0M | $656.0M | $1.0B | $463.0M | $462.0M | $463.0M | $462.0M | $353.4M | $125.3M | $124.9M | $72.3M |
| Depreciation & Amortization | $270.0M | $354.0M | $432.0M | $187.0M | $251.0M | $187.0M | $188.0M | $141.0M | $127.0M | $141.0M | $127.0M | $112.6M | $50.8M | $34.2M | $24.5M |
| Operating Cash Flow | $1.1B | $837.0M | $478.0M | $1.1B | $545.0M | $1.1B | $1.1B | $779.0M | $786.0M | $779.0M | $786.0M | $501.3M | $386.4M | $272.6M | $172.2M |
| Capital Expenditures | $148.0M | $128.0M | $195.0M | $189.0M | $208.0M | $189.0M | $209.0M | $260.0M | $143.0M | $260.0M | $143.0M | $106.0M | $79.2M | $49.8M | $52.7M |
| Free Cash Flow | $931.0M | $709.0M | $283.0M | $891.0M | $337.0M | $891.0M | $842.0M | $519.0M | $643.0M | $519.0M | $643.0M | $395.3M | $307.2M | $222.8M | $119.5M |
| Share Buybacks | $742.0M | $116.0M | $0 | $736.0M | $0 | $736.0M | $324.0M | $249.0M | $274.0M | $249.0M | $274.0M | $237.2M | $50.0M | $44.0M | $175.1M |
| FCF Margin | 21.4% | 16.2% | 6.3% | 27.5% | 7.4% | 27.5% | 23.8% | 21.6% | 29.0% | 21.6% | 29.0% | 21.2% | 21.6% | 24.7% | 17.9% |